Oxbow Advisors, LLC Abbott Laboratories Transaction History

Oxbow Advisors, LLC

$891 Million
Q3 2024

A detailed history of Oxbow Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Oxbow Advisors, LLC holds 8,647 shares of ABT stock, worth $996,739. This represents 0.11% of its overall portfolio holdings.

Number of Shares

8,647

Previous 8,752 1.2%

Holding current value

$996,739

Previous $909,000 8.36%

% of portfolio

0.11%

Previous 0.12%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$100.07 - $118.13 $10,507 - $12,403	-105 Reduced 1.2%	8,647 $985,000
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $705 - $787	-7 Reduced 0.08%	8,752 $909,000
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $39,208 - $43,303	358 Added 4.26%	8,759 $995,000
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $15,151 - $18,547	-168 Reduced 1.96%	8,401 $924,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $20,921 - $25,101	219 Added 2.62%	8,569 $829,000
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $9,876 - $11,004	98 Added 1.19%	8,350 $910,000
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $12,385 - $14,339	128 Added 1.58%	8,252 $798,000
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $3,062 - $3,701	30 Added 0.37%	8,124 $883,000
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $112,651 - $137,371	988 Added 13.9%	8,094 $958,000
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $22,759 - $27,867	197 Added 2.85%	7,106 $1 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $60,779 - $67,240	-521 Reduced 7.01%	6,909 $816,000
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $41,359 - $48,727	380 Added 5.39%	7,430 $890,000
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $64,050 - $69,796	610 Added 9.47%	7,050 $772,000
Q3 2020 Nov 06, 2020	BUY	$91.64 - $111.29 $7,697 - $9,348	84 Added 1.32%	6,440 $701,000
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $16,768 - $21,462	-219 Reduced 3.33%	6,356 $581,000
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $8,857 - $12,952	-141 Reduced 2.1%	6,575 $519,000
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $62,808 - $69,920	-800 Reduced 10.64%	6,716 $583,000
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $3,273 - $3,549	-40 Reduced 0.53%	7,516 $629,000
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $2,186 - $2,550	-30 Reduced 0.4%	7,556 $635,000
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $40,725 - $49,236	-615 Reduced 7.5%	7,586 $606,000
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $61,757 - $69,962	942 Added 12.98%	8,201 $593,000
Q3 2018 Nov 06, 2018	BUY	$60.81 - $73.36 $60 - $73	1 Added 0.01%	7,259 $533,000
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $57 - $63	1 Added 0.01%	7,258 $443,000
Q1 2018 Apr 30, 2018	BUY	$56.27 - $63.62 $10,184 - $11,515	181 Added 2.56%	7,257 $435,000
Q4 2017 Jan 30, 2018	BUY	$53.68 - $57.47 $53 - $57	1 Added 0.01%	7,076 $404,000
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $340,024 - $379,503	7,075	7,075 $378,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxbow Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxbow Advisors, LLC with notifications on news.

Account

Oxbow Advisors, LLC Abbott Laboratories Transaction History